Brussels, 17/07/2009 (Agence Europe) - The new Belgian law, which exempts all medicines made from blood from the levy on the turnover of pharmaceutical companies, is in line with Community regulations, the European Commission announced on Thursday 16 July. The Commission decided that demand for this kind of medicine was not affected by production costs: tax exemption, then, did not constitute state aid that could lead to competitive advantage. The Commission took the view, therefore, that it...